These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21410302)

  • 1. The role of β-blockers in the management of hypertension: an Asian perspective.
    Tomlinson B; Dalal JJ; Huang J; Low LP; Park CG; Rahman AR; Reyes EB; Soenarta AA; Heagerty A; Follath F
    Curr Med Res Opin; 2011 May; 27(5):1021-33. PubMed ID: 21410302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH; Bangalore S; Yao SS; Steinberg JS
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How useful are beta-blockers in cardiovascular disease?
    Bangalore S; Parkar S; Messerli FH
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):358-63. PubMed ID: 17162285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS
    Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists.
    Frohlich ED
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):455-64. PubMed ID: 19897523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S; Messerli FH; Kostis JB; Pepine CJ
    J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current state of beta blockers in hypertension therapy.
    Lardizabal JA; Deedwania PC
    Indian Heart J; 2010; 62(2):111-7. PubMed ID: 21180299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies.
    Domanski D; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):258-68. PubMed ID: 19734324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why beta-blockers should not be used as first choice in uncomplicated hypertension.
    De Caterina AR; Leone AM
    Am J Cardiol; 2010 May; 105(10):1433-8. PubMed ID: 20451690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers in hypertension.
    Hansson L
    J Hypertens Suppl; 1987 Aug; 5(3):S61-7. PubMed ID: 2889813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers for primary prevention in hypertension: era bygone?
    Panjrath GS; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(2):76-87. PubMed ID: 17046433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
    Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
    Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure guidelines - where are we now?
    Drug Ther Bull; 2008 Sep; 46(9):65-9. PubMed ID: 18784380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers in hypertension.
    Ram CV
    Am J Cardiol; 2010 Dec; 106(12):1819-25. PubMed ID: 21126627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.